Mentice AB (publ) (STO:MNTC)
Sweden · Delayed Price · Currency is SEK 13.60
-0.45 (-3.20%)
Aug 6, 2025, 5:29 PM CET
ShockWave Medical Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 261.61 | 290.33 | 273.61 | 217.95 | 185.06 | 137.5 | Upgrade |
Other Revenue | 2.33 | 1.48 | 1.51 | 1.46 | - | - | Upgrade |
| 263.95 | 291.81 | 275.12 | 219.42 | 185.06 | 137.5 | Upgrade | |
Revenue Growth (YoY) | -6.86% | 6.07% | 25.39% | 18.56% | 34.59% | -7.95% | Upgrade |
Cost of Revenue | 25.23 | 33.08 | 37.23 | 29.01 | 34.95 | 33.4 | Upgrade |
Gross Profit | 238.71 | 258.73 | 237.9 | 190.41 | 150.11 | 104.11 | Upgrade |
Selling, General & Admin | 253.56 | 239.14 | 210.87 | 192.33 | 152.62 | 121.55 | Upgrade |
Operating Expenses | 287.22 | 269.72 | 238.57 | 215.26 | 172.78 | 135.69 | Upgrade |
Operating Income | -48.51 | -11 | -0.68 | -24.86 | -22.67 | -31.59 | Upgrade |
Interest Expense | -0.58 | -1.22 | -1.18 | -1.37 | -0.54 | -0.54 | Upgrade |
Interest & Investment Income | 0.76 | 1.56 | 1.26 | - | 0 | 0.01 | Upgrade |
Currency Exchange Gain (Loss) | -1.45 | -1.45 | 0.59 | 2.19 | 4.29 | 7.38 | Upgrade |
Other Non Operating Income (Expenses) | 0 | -0 | - | 0.01 | - | -0.01 | Upgrade |
EBT Excluding Unusual Items | -49.78 | -12.1 | -0.01 | -24.04 | -18.92 | -24.75 | Upgrade |
Asset Writedown | - | - | - | - | -2.2 | - | Upgrade |
Other Unusual Items | -1.4 | -1.4 | - | - | -0.15 | 6.16 | Upgrade |
Pretax Income | -51.18 | -13.5 | -0.01 | -24.04 | -21.27 | -18.59 | Upgrade |
Income Tax Expense | 4.92 | 4.92 | 2.81 | 6.63 | 7.92 | -5.49 | Upgrade |
Net Income to Company | - | -18.42 | -2.82 | -30.67 | -29.19 | -13.09 | Upgrade |
Net Income | -56.1 | -18.42 | -2.82 | -30.67 | -29.19 | -13.09 | Upgrade |
Net Income to Common | -56.1 | -18.42 | -2.82 | -30.67 | -29.19 | -13.09 | Upgrade |
Shares Outstanding (Basic) | 26 | 26 | 26 | 25 | 25 | 24 | Upgrade |
Shares Outstanding (Diluted) | 26 | 26 | 26 | 25 | 25 | 24 | Upgrade |
Shares Change (YoY) | -1.63% | - | 1.42% | 1.80% | 1.97% | 24.20% | Upgrade |
EPS (Basic) | -2.19 | -0.72 | -0.11 | -1.22 | -1.18 | -0.54 | Upgrade |
EPS (Diluted) | -2.19 | -0.72 | -0.11 | -1.22 | -1.18 | -0.54 | Upgrade |
Free Cash Flow | -2.78 | 16.64 | 32.19 | 9.38 | -14.18 | 27.26 | Upgrade |
Free Cash Flow Per Share | -0.11 | 0.65 | 1.26 | 0.37 | -0.57 | 1.12 | Upgrade |
Gross Margin | 90.44% | 88.66% | 86.47% | 86.78% | 81.11% | 75.71% | Upgrade |
Operating Margin | -18.38% | -3.77% | -0.25% | -11.33% | -12.25% | -22.97% | Upgrade |
Profit Margin | -21.25% | -6.31% | -1.02% | -13.98% | -15.77% | -9.52% | Upgrade |
Free Cash Flow Margin | -1.05% | 5.70% | 11.70% | 4.28% | -7.66% | 19.82% | Upgrade |
EBITDA | -36.38 | -2.97 | 11.38 | -16.96 | -16.74 | -26.16 | Upgrade |
EBITDA Margin | -13.78% | -1.02% | 4.14% | -7.73% | -9.04% | -19.02% | Upgrade |
D&A For EBITDA | 12.13 | 8.03 | 12.06 | 7.9 | 5.94 | 5.43 | Upgrade |
EBIT | -48.51 | -11 | -0.68 | -24.86 | -22.67 | -31.59 | Upgrade |
EBIT Margin | -18.38% | -3.77% | -0.25% | -11.33% | -12.25% | -22.97% | Upgrade |
Revenue as Reported | 263.94 | 291.81 | 275.12 | 220.32 | 190.22 | 150.88 | Upgrade |
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.